Sources | Names Used |
---|---|
CTRPv2 | carboplatin:etoposide (40:17 mol/mol) |
PharmacoGx | carboplatin:etoposide (40:17 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-20 |
mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-18 |
mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-18 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-18 |
mRNA | HNRNPDL | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-18 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-17 |
mRNA | SLFN11 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-17 |
mRNA | ZNF445 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-16 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-16 |
mRNA | CDCA7 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-16 |